Please use symbol entry at top right of page to search
|
Psychedelics Investor Acquires Firm With First-Mover Advantage In Safe Supply Narcotics SectorLate Tuesday, Origin Therapeutics Holdings Inc. (CSE:ORIG), an investment issuer that has historically focused on psychedelics-industry-related companies announced it had signed a binding Letter of Intent (LOI) to acquire all of the issued and outstanding securities of Safe Supply Streaming Co., a pharmaceutical streaming and investment company in the safe supply eco-system. Completion of the transaction is anticipated to create the world's first publicly-listed pharmaceutical and narcotics investment company "aimed at creating a global powerhouse positioned to take advantage of the rapidly growing safe supply narcotic sector and entire eco-system," according to Origin. "This is a major milestone for Canadian political history and represents the third and final wave of de-scheduling narcotics here in " Pursuant to the terms of the LOI and other terms to be agreed upon, Origin has agreed to lend up to Completion of the transaction is subject to a number of conditions, including:
"Pursuant to the Transaction, all outstanding securities of Safe Supply will be exchanged by the holders thereof for identical securities of the Resulting Issuer on a post-Consolidation one-for-one basis," per a company press release. Image Credits: Anaterate, Sergeitokmakov by Pixabay Edited By Benzinga More Sectors NewsSearch NewsFilter ResultsPublication DateTopicProvider |
News, commentary and research reports are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.